Baidu In Talks With Investors To Gear Up $2B For BioTech Startup – Report
Pfizer, BioNTech Set To Supply EU With 200M Covid-19 Vaccine Doses
OECD Exposes 15 Trillion Reasons Why US Schools Need To Open Now!
Futures Rebound, Oil Jumps After Relentless 3-Day Hammering
US Open – Tech Finding its Feet
Australian Dollar Holds Ground Despite Risk Aversion
Macro Briefing | 9 September 2020
AZ halts COVID-19 vaccine after safety scare, as UK faces ‘second wave’
AstraZeneca puts leading Covid-19 vaccine trial on hold over safety concern
Tokyo Olympics Will Happen In 2021 'With Or Without Coronavirus': IOC VP
AstraZeneca Shares Plunge As COVID Vaccine Study Put On Hold Due To "Adverse Reaction"
COVID19 vaccine makers’ pledge no better than NRA’s promises
How COVID-19 has changed the way we spend
3M awards philanthropic grant to Tel Aviv University for COVID-19 vaccine research
A Shot in the Arm
August ETF flows: Once more unto the breach
Tuesday’s Market Snapshot: Here’s What You Need To Know Right Now
Scientists develop low-cost chip to detect presence and quantity of COVID-19 antibodies
Airlines, Officials, Lying About COVID Flying Risks
News briefing: Exelixis rolls the dice with 2 ADC deals tied to $35M cash upfronts; A rare antibiotic win for prominently-backed Spero
Covid-19 roundup: After batting back at vaccine supplier, Inovio lines up a giant in its corner; Oxford spinout SpyBiotech begins PhI/II dosing for VLP-based vaccine
AstraZeneca’s Covid-19 Vaccine ‘Most Likely’ To Be Available In UK In Early 2021
Mylan To Snap Up Aspen’s Thrombosis Unit For $757M As Street Is Bullish
Spain First In Western Europe To Top 500k COVID-19 Cases As "Second Wave" Intensifies: Live Updates
Trump will not interfere with vaccine approval process, FDA chief reassures staff
How the government can drive medical innovation amidst the pandemic
J&J Gets European Nod For Expanded Blood Cancer Treatment
Pharma ‘must not dodge liability for harm in COVID-19 vaccine trials’
Byron Wien Warns "This Market Is Vulnerable"
Oxford scientists: these are final steps we're taking to get our coronavirus vaccine approved